Extracorporeal photochemotherapy for graft versus host disease in pediatric patients
- 28 February 2003
- journal article
- review article
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 28 (1) , 71-80
- https://doi.org/10.1016/s1473-0502(02)00102-7
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- How I treat chronic graft-versus-host diseaseBlood, 2001
- Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot studyBlood, 2000
- Statement of current majority practices in graft-versus-host disease prophylaxis and treatment in childrenBone Marrow Transplantation, 2000
- Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host diseaseBlood, 2000
- Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimusBone Marrow Transplantation, 1999
- Allogeneic Bone Marrow Transplantation for Hematological Malignancies–Controversies and Recent AdvancesActa Oncologica, 1997
- Thalidomide for the Treatment of Chronic Graft-versus-Host DiseaseNew England Journal of Medicine, 1992
- 8-METHOXYPSORALEN AND ULTRAVIOLET A THERAPY FOR CUTANEOUS MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASETransplantation, 1990
- Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10) [see comments]Blood, 1990
- Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host diseaseBlood, 1988